{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:03:35Z","timestamp":1790183015508,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":1012,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1R01AI139141\u201001A1"],"award-info":[{"award-number":["1R01AI139141\u201001A1"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1R56AI139141\u201001"],"award-info":[{"award-number":["1R56AI139141\u201001"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1111\/ajt.15634","type":"journal-article","created":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T05:04:04Z","timestamp":1570597444000},"page":"399-410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Proteasomal adaptations underlying carfilzomib-resistance in human bone marrow plasma cells"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4280-0842","authenticated-orcid":false,"given":"E. Steve","family":"Woodle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1070-9315","authenticated-orcid":false,"given":"Simon","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Brailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alin","family":"Girnita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita R.","family":"Alloway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Aronow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nupur","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Ebstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter-Michael","family":"Kloetzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Jae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung B.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8364-0617","authenticated-orcid":false,"given":"James J.","family":"Driscoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/ajt.15634_bib1","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJMoa1411321","article-title":"Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma","volume":"372","author":"Stewart","year":"2015","journal-title":"N Engl J Med."},{"key":"10.1111\/ajt.15634_bib2","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa043445","article-title":"Bortezomib or high-dose dexamethasone for relapsed multiple myeloma","volume":"352","author":"Richardson","year":"2005","journal-title":"N Engl J Med."},{"key":"10.1111\/ajt.15634_bib3","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJMoa1516282","article-title":"Oral ixazomib, lenalidomide, and dexamethasone for multiple myeloma","volume":"374","author":"Moreau","year":"2016","journal-title":"N Engl J Med."},{"issue":"12","key":"10.1111\/ajt.15634_bib4","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1097\/TP.0b013e318190af83","article-title":"Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection","volume":"86","author":"Everly","year":"2008","journal-title":"Transplantation."},{"key":"10.1111\/ajt.15634_bib5","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2215\/CJN.05021107","article-title":"Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation\/Kidney Disease Outcomes Quality Initiative (NKF\/KDOQITM) conference","volume":"3","author":"Abecassis","year":"2018","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1111\/ajt.15634_bib6","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1681\/ASN.2011010023","article-title":"Trends in the timing of pre-emptive kidney transplantation","volume":"22","author":"Grams","year":"2015","journal-title":"J Am Soc Nephrol."},{"issue":"8","key":"10.1111\/ajt.15634_bib7","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.2215\/CJN.02480218","article-title":"Opportunities for increasing the rate of preemptive kidney transplantation","volume":"13","author":"Fishbane","year":"2018","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1111\/ajt.15634_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/MOT.0000000000000262","article-title":"Mechanisms of antibody-mediated acute and chronic rejection of kidney allografts","volume":"21","author":"Baldwin","year":"2016","journal-title":"Curr Opin Organ Transplant."},{"issue":"Suppl. 3","key":"10.1111\/ajt.15634_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ajt.14584","article-title":"Antibody-mediated rejection: new approaches in prevention and management","volume":"18","author":"Montgomery","year":"2018","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15634_bib10","first-page":"46","article-title":"Antibody-mediated rejection: a review","volume":"17","author":"Garces","year":"2017","journal-title":"Ochsner J."},{"key":"10.1111\/ajt.15634_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.healun.2005.09.003","article-title":"Acute antibody-mediated rejection of cardiac transplants","volume":"25","author":"Reed","year":"2006","journal-title":"J Heart Lung Transplant."},{"key":"10.1111\/ajt.15634_bib12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/MOT.0b013e3283614a5c","article-title":"Pancreas transplantation, antibodies and rejection: where do we stand?","volume":"18","author":"de Kort","year":"2013","journal-title":"Curr Opin Organ Transplant."},{"key":"10.1111\/ajt.15634_bib13","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1749-6632.1996.tb52958.x","article-title":"Long-term antibody production is sustained by antibody-secreting cells in the bone marrow following acute viral infection","volume":"797","author":"Slifka","year":"1996","journal-title":"Ann N Y Acad Sci."},{"key":"10.1111\/ajt.15634_bib14","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1074-7613(04)00112-8","article-title":"Pathogenic roles of B cells in human autoimmunity: insights from the clinic","volume":"20","author":"Martin","year":"2004","journal-title":"Immunity."},{"key":"10.1111\/ajt.15634_bib15","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1016\/j.transproceed.2010.09.043","article-title":"Desensitization protocol in highly HLA-sensitized and ABO-incompatible high titer kidney transplantation","volume":"42","author":"Uchida","year":"2010","journal-title":"Transplant Proc."},{"issue":"2","key":"10.1111\/ajt.15634_bib16","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1600-6143.2006.01632.x","article-title":"The effect of desensitization protocols on human splenic B-cell populations in vivo","volume":"7","author":"Ramos","year":"2007","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15634_bib17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa0707894","article-title":"Rituximab and intravenous immune globulin for desensitization during renal transplantation","volume":"359","author":"Vo","year":"2008","journal-title":"N Engl J Med."},{"key":"10.1111\/ajt.15634_bib18","doi-asserted-by":"crossref","first-page":"6804678","DOI":"10.1155\/2017\/6804678","article-title":"Desensitization: overcoming the immunologic barriers to transplantation","volume":"2017","author":"Sethi","year":"2017","journal-title":"J Immunol Res."},{"key":"10.1111\/ajt.15634_bib19","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1189\/jlb.1011497","article-title":"Pivotal advance: protein synthesis modulates responsiveness of differentiating and malignant plasma cells to proteasome inhibitors","volume":"92","author":"Cenci","year":"2012","journal-title":"J Leukoc Biol."},{"key":"10.1111\/ajt.15634_bib20","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1158\/1535-7163.MCT-04-0338","article-title":"Proteasome inhibitor therapy in multiple myeloma","volume":"4","author":"Chauhan","year":"2005","journal-title":"Mol Cancer Ther."},{"key":"10.1111\/ajt.15634_bib21","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1146\/annurev.biochem.78.081507.101607","article-title":"Recognition and processing of ubiquitin-protein conjugates by the proteasome","volume":"78","author":"Finley","year":"2009","journal-title":"Annu Rev Biochem."},{"key":"10.1111\/ajt.15634_bib22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/35056572","article-title":"Antigen processing by the proteasome","volume":"2","author":"Kloetzel","year":"2001","journal-title":"Nat Rev Mol Cell Biol."},{"key":"10.1111\/ajt.15634_bib23","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1007\/s00018-012-0938-0","article-title":"Emerging roles of immunoproteasomes beyond MHC class I antigen processing","volume":"69","author":"Ebstein","year":"2012","journal-title":"Cell Mol Life."},{"issue":"Suppl 3","key":"10.1111\/ajt.15634_bib24","first-page":"315","article-title":"A prospective carfilzomib-based desensitization trial: phase 1 results","volume":"16","author":"Tremblay","year":"2016","journal-title":"Am J Transplant."},{"issue":"1","key":"10.1111\/ajt.15634_bib25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/ajt.13050","article-title":"Prospective iterative trial of proteasome inhibitor-based desensitization","volume":"15","author":"Woodle","year":"2015","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15634_bib26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.smim.2007.12.002","article-title":"Plasma cell development: From B-cell subsets to long-term survival niches","volume":"20","author":"Fairfax","year":"2008","journal-title":"Semin Immunol."},{"key":"10.1111\/ajt.15634_bib27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-6143.2008.02461.x","article-title":"Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production","volume":"9","author":"Perry","year":"2009","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15634_bib28","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/TP.0b013e3182081333","article-title":"The impact of proteasome inhibition on alloantibody-producing plasma cells in vivo","volume":"91","author":"Diwan","year":"2011","journal-title":"Transplantation."},{"key":"10.1111\/ajt.15634_bib29","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ab.2009.01.016","article-title":"Cell-based bioluminescent assays for all three proteasome activities in a homogeneous format","volume":"387","author":"Moravec","year":"2009","journal-title":"Anal Biochem."},{"issue":"12","key":"10.1111\/ajt.15634_bib30","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.4049\/jimmunol.1103720","article-title":"In vitro generation of long-lived human plasma cells","volume":"189","author":"Cocco","year":"2012","journal-title":"J Immunol."},{"key":"10.1111\/ajt.15634_bib31","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1182\/blood-2009-07-235960","article-title":"An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization","volume":"114","author":"Jourdan","year":"2014","journal-title":"Blood."},{"issue":"8","key":"10.1111\/ajt.15634_bib32","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1038\/leu.2014.61","article-title":"IL-6 supports the generation of human long-lived plasma cells in combination with either APRIL or stromal cell-soluble factors","volume":"28","author":"Jourdan","year":"2014","journal-title":"Leukemia."},{"key":"10.1111\/ajt.15634_bib33","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.4049\/jimmunol.169.8.4213","article-title":"The role of bone marrow-derived stromal cells in the maintenance of plasma cell longevity","volume":"169","author":"Wols","year":"2002","journal-title":"J Immunol."},{"key":"10.1111\/ajt.15634_bib34","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0076-6879(05)98029-4","article-title":"Characterization of the proteasome using native gel electrophoresis","volume":"398","author":"Elsasser","year":"2005","journal-title":"Methods Enzymol."},{"key":"10.1111\/ajt.15634_bib35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/15321819.2015.1042544","article-title":"Interaction of proteasomes and complement C3, assay of antisecretory factor in blood","volume":"37","author":"L\u00f6nnroth","year":"2016","journal-title":"J Immunoassay Immunochem."},{"issue":"52","key":"10.1111\/ajt.15634_bib36","doi-asserted-by":"crossref","first-page":"E8425","DOI":"10.1073\/pnas.1618548114","article-title":"Brief treatment with a highly selective immunoproteasome inhibitor promotes long-term cardiac allograft acceptance in mice","volume":"113","author":"Sula Karreci","year":"2016","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1111\/ajt.15634_bib37","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ajhg.2010.10.031","article-title":"PSMB8 encoding the \u03b25i proteasome subunit is mutated in joint contractures, muscle atrophy, microcytic anemia, and panniculitis-induced lipodystrophy syndrome","volume":"87","author":"Agarwal","year":"2010","journal-title":"Am J Hum Genet."},{"issue":"10","key":"10.1111\/ajt.15634_bib38","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1172\/JCI58414","article-title":"A mutation in the immunoproteasome subunit PSMB8 causes autoinflammation and lipodystrophy in humans","volume":"121","author":"Kitamura","year":"2011","journal-title":"J Clin Invest."},{"key":"10.1111\/ajt.15634_bib39","doi-asserted-by":"crossref","first-page":"14914","DOI":"10.1073\/pnas.1106015108","article-title":"Proteasome assembly defect due to a proteasome subunit beta type 8 (PSMB8) mutation causes the autoinflammatory disorder, Nakajo-Nishimura syndrome","volume":"108","author":"Arima","year":"2011","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1111\/ajt.15634_bib40","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jaad.2009.04.046","article-title":"Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome","volume":"62","author":"Torrelo","year":"2010","journal-title":"J Am Acad Dermatol."},{"key":"10.1111\/ajt.15634_bib41","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1172\/JCI81260","article-title":"Additive loss-of-function proteasome subunit mutations in CANDLE\/PRAAS patients promote type I IFN production","volume":"125","author":"Brehm","year":"2015","journal-title":"J Clin Invest."},{"key":"10.1111\/ajt.15634_bib42","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/1529-0131(199803)41:3<560::AID-ART24>3.0.CO;2-P","article-title":"Association of large molecular weight proteasome 7 gene polymorphism with ankylosing spondylitis","volume":"41","author":"Fraile","year":"1998","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1111\/ajt.15634_bib43","first-page":"528","article-title":"Association of LMP2 and LMP7 genes within the major histocompatibility complex with insulin-dependent diabetes mellitus: population and family studies","volume":"56","author":"Deng","year":"1995","journal-title":"Am J Hum Genet."},{"key":"10.1111\/ajt.15634_bib44","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nm.1978","article-title":"A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis","volume":"15","author":"Muchamuel","year":"2009","journal-title":"Nat Med."},{"key":"10.1111\/ajt.15634_bib45","doi-asserted-by":"crossref","first-page":"634","DOI":"10.4049\/jimmunol.0903182","article-title":"Prevention of experimental colitis by a selective inhibitor of the immunoproteasome","volume":"185","author":"Basler","year":"2010","journal-title":"J Immunol."},{"key":"10.1111\/ajt.15634_bib46","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1365-2249.2012.04578.x","article-title":"Prophylactic and therapeutic efficacies of a selective inhibitor of the immunoproteasome for Hashimoto\u2019s thyroiditis, but not for Graves\u2019 hyperthyroidism, in mice","volume":"168","author":"Nagayama","year":"2012","journal-title":"Clin Exp Immunol."},{"issue":"9","key":"10.1111\/ajt.15634_bib47","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.bbmt.2015.06.010","article-title":"Inhibition of the immunoproteasome subunit LMP7 with ONX0914 ameliorates graft-versus-host disease in an MHC-matched minor histocompatibility antigen-disparate murine model","volume":"21","author":"Silberberg","year":"2015","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1111\/ajt.15634_bib48","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1097\/TP.0b013e318218e901","article-title":"Early and late acute antibody-mediated rejection differ immunologically and in response to proteasome inhibition","volume":"91","author":"Walsh","year":"2011","journal-title":"Transplantation."},{"key":"10.1111\/ajt.15634_bib49","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/ajt.12287","article-title":"Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA","volume":"13","author":"Reed","year":"2013","journal-title":"Am J Transplant."}],"updated-by":[{"DOI":"10.1111\/ajt.16146","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000}}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15634","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.15634","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522221935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522221935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15634","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,22]],"date-time":"2023-01-22T15:52:45Z","timestamp":1674402765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522221935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1600613522221935"],"URL":"https:\/\/doi.org\/10.1111\/ajt.15634","relation":{"erratum":[{"id-type":"doi","id":"10.1111\/ajt.16146","asserted-by":"object"}]},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proteasomal adaptations underlying carfilzomib-resistance in human bone marrow plasma cells","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.15634","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}